Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry

INTRODUCTION: To compare the efficacy of abatacept and tumor necrosis factor inhibitor (TNFi) in patients with anti-citrullinated protein antibody (ACPA)-positive rheumatoid arthritis (RA) and identify those who benefit most from abatacept over TNFi. METHODS: This observational study identified RA p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Jung, Lee, Sun-Kyung, Oh, Sohee, Kim, Hyoun-Ah, Park, Yong-Beom, Lee, Shin-Seok, Shin, Kichul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314478/
https://www.ncbi.nlm.nih.gov/pubmed/35716235
http://dx.doi.org/10.1007/s40744-022-00467-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314478/
https://www.ncbi.nlm.nih.gov/pubmed/35716235
http://dx.doi.org/10.1007/s40744-022-00467-4

Ejemplares similares